The impact of gout on patient's lives: A study of African-American and Caucasian men and women with gout

Arthritis Research and Therapy

Volumn 16, Issue 3, 2014, Pages

  Singh, Jasvinder A ^a,b,c  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; CANE; CAUCASIAN; CRUTCH; DIET RESTRICTION; EMOTIONAL STABILITY; FEMALE; GOUT; HUMAN; JOINT SWELLING; LIMB DEFORMITY; MAJOR CLINICAL STUDY; MALE; PAIN; QUALITY OF LIFE; RACE DIFFERENCE; SEX DIFFERENCE; SEXUAL FUNCTION; WORK DISABILITY; ARTHRALGIA; EMOTIONAL DISORDER; ETHNOLOGY; OUTPATIENT; PSYCHOLOGY; SLEEP DISORDER; STATISTICS AND NUMERICAL DATA; ADULT; CONTROLLED STUDY; EMPLOYABILITY; LEISURE; PRODUCTIVITY; QUALITATIVE RESEARCH; SHOE; SOCIAL LIFE; WORK CAPACITY;

AFFECTIVE SYMPTOMS; AFRICAN AMERICANS; AGED; ARTHRALGIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GOUT; HUMANS; MALE; OUTPATIENTS; QUALITY OF LIFE; SEX FACTORS; SLEEP DISORDERS;

EID: 84904649885     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4589     Document Type: Article

References (50)

1. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011, 63:3136-3141. 10.1002/art.30520, 21800283.
2. Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum 2007, 57:822-829. 10.1002/art.22767, 3619972, 17530682.
3. Garg R, Sayles HR, Yu F, Michaud K, Singh J, Saag KG, Mikuls TR. Gout-related health care utilization in US emergency departments, 2006 through 2008. Arthritis Care Res (Hoboken) 2013, 65:571-577. Epub 2012/09/06.
4. Wertheimer AI, Morlock R, Becker MA. A Revised Estimate of the Burden of Illness of Gout. Curr Ther Res 2013, 75:1-4. 3898191, 24465034.
5. Singh JA, Hodges JS, Asch SM. Opportunities for improving medication use and monitoring in gout. Ann Rheum Dis 2009, 68:1265-1270. 10.1136/ard.2008.092619, 18701554.
6. Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 2009, 11:R46. 10.1186/ar2659, 2688196, 19327147.
7. Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis 2006, 65:1368-1372. 10.1136/ard.2006.051649, 1798311, 16644784.
8. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Saag KG. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 2005, 44:1038-1042. 10.1093/rheumatology/keh679, 15870145.
9. Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, Bakst AW. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006, 81:925-934. 10.4065/81.7.925, 16835972.
10. Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 2006, 12:61-65. 10.1097/01.rhu.0000209882.50228.9f, 16601538.
11. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liote F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012 2012, 64:1431-1446.
12. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liote F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentao J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gorska I. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006, 65:1312-1324. 10.1136/ard.2006.055269, 1798308, 16707532.
13. Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013, 15:307. 3545402, 23315156.
14. Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol 2008, 35:498-501.
15. Solomon DH, Avorn J, Levin R, Brookhart MA. Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 2008, 67:609-613.
16. Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol 1995, 48:1153-1158. 10.1016/0895-4356(94)00244-K, 7636517.
17. Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, Horne A, Gamble G, McQueen FM, Taylor WJ. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability. Arthritis Care Res (Hoboken) 2011, 63:1605-1612. 10.1002/acr.20570, 22034122.
18. Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, Vietri J, Khanna D. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health Qual Life Outcomes 2012, 10:117. 10.1186/1477-7525-10-117, 3499162, 22999027.
19. Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, Kavanaugh A. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford) 2009, 48:582-586. 2722803, 19307257.
20. Roddy E, Zhang W, Doherty M. Is gout associated with reduced quality of life? A case-control study. Rheumatology (Oxford) 2007, 46:1441-1444. 10.1093/rheumatology/kem150, 17586863.
21. Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis 2008, 67:1310-1316.
22. Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology (Oxford) 2011, 50:740-745. 10.1093/rheumatology/keq346, 3060621, 21147824.
23. Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW, Hamburger SA, Becker MA. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011, 306:711-720.
24. Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA. Patients and providers view gout differently: a qualitative study. Chronic Illn 2010, 6:263-271. 10.1177/1742395310378761, 3134238, 20675361.
25. Spencer K, Carr A, Doherty M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Ann Rheum Dis 2012, 71:1490-1495. 10.1136/annrheumdis-2011-200801, 22440822.
26. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 2011, 17:1-6. 10.1097/RHU.0b013e318204a8f9, 21169857.
27. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum 2008, 58:15-25.
28. Corbin J, Strauss AL. Accompaniments of chronic illness: changes in body, self, biography, and biographical time. Research in the Sociology of Health Care: A Research Annual. Vol. 6. The Experience and Management of Chronic Illness Greenwich, Vol. 6 1987, 249-281. Greenwich, CT: JAI Press, Inc, Roth JA, Conrad P.
29. Corbin JM, Strauss AL. Experiencing body failure and a disrupted self image. Unending Work and Care: Managing Chronic Illness at Home 1988, 49-67. San Francisco, Calif: Jossey-Bass, Corbin J, Strauss AL.
30. Lambert BL, Street RL, Cegala DJ, Smith H, Kurtz S, Schofield T. Provider-patient communication, patient-centered care, and the mangle of practice. Health Commun 1997, 9:27-43.
31. Charmaz K. Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn 1987, 5:168-195.
32. Gallagher M, Hares T, Spencer J, Bradshaw C, Webb I. The nominal group technique: a research tool for general practice?. Fam Pract 1993, 10:76-81. 10.1093/fampra/10.1.76, 8477899.
33. Miller D, Shewchuk R, Elliot TR, Richards S. Nominal group technique: a process for identifying diabetes self-care issues among patients and caregivers. Diabetes Educ 2000, 26:305-310. 312, 314, 10.1177/014572170002600211, 10865596.
34. Jefferson WK, Zunker C, Feucht JC, Fitzpatrick SL, Greene LF, Shewchuk RM, Baskin ML, Walton NW, Phillips B, Ard JD. Use of the Nominal Group Technique (NGT) to understand the perceptions of the healthiness of foods associated with African Americans. Eval Program Plann 2010, 33:343-348. 10.1016/j.evalprogplan.2009.11.002, 20047762.
35. Kleiner-Fisman G, Gryfe P, Naglie G. A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique. Park Dis 2013, 2013:974964.
36. MacLachlan M. Identifying problems in community health promotion: an illustration of the Nominal Group Technique in AIDS education. J R Soc Health 1996, 116:143-148. 10.1177/146642409611600303, 8691395.
37. Pastrana T, Radbruch L, Nauck F, Hover G, Fegg M, Pestinger M, Ross J, Krumm N, Ostgathe C. Outcome indicators in palliative care-how to assess quality and success, Focus group and nominal group technique in Germany. Support Care Cancer 2010, 18:859-868. 10.1007/s00520-009-0721-4, 3128732, 19701782.
38. Pena A, Estrada CA, Soniat D, Taylor B, Burton M. Nominal group technique: a brainstorming tool for identifying areas to improve pain management in hospitalized patients. J Hosp Med 2012, 7:416-420. 10.1002/jhm.1900, 22190453.
39. Redman S, Carrick S, Cockburn J, Hirst S. Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique. Aust N Z J Public Health 1997, 21:250-256. 10.1111/j.1467-842X.1997.tb01695.x, 9270149.
40. Singh JA. Challenges faced by patients in gout treatment: a qualitative study. J Clin Rheumatol 2014, 20(3):172-174.
41. Singh JA. Research priorities in gout: the patient perspective. J Rheumatol 2014, 41(3):615-616. 10.3899/jrheum.131258, 24585526.
42. Harrold LR, Mazor KM, Peterson D, Naz N, Firneno C, Yood R. Patients' knowledge and beliefs concerning gout and its treatment: a population based study. BMC Musculoskelet Disord 2012, 13:180. 10.1186/1471-2474-13-180, 3517442, 22995041.
43. Covarrubias-Gomez A, Guevara-Lopez U, Haro-Valencia R, Alvarado-Suarez M. Importance of the obstructive sleep apnea disorder for perioperative medicine. Rev Med Inst Mex Seguro Soc 2007, 45:371-380.
44. Guevara-Lopez U, Ayala-Guerrero F, Covarrubias-Gomez A, Lopez-Munoz FJ, Torres-Gonzalez R. Effect of acute gouty arthritis on sleep patterns: a preclinical study. Eur J Pain 2009, 13:146-153. 10.1016/j.ejpain.2008.04.002, 18501649.
45. Westhovens R, Van der Elst K, Matthys A, Tran M, Gilloteau I. Sleep problems in patients with rheumatoid arthritis. J Rheumatol 2014, 41:31-40. Epub 2013/12/03, 10.3899/jrheum.130430, 24293569.
46. Abbasi M, Yazdi Z, Rezaie N. Sleep disturbances in patients with rheumatoid arthritis. Niger J Med 2013, 22:181-186.
47. Fragiadaki K, Tektonidou MG, Konsta M, Chrousos GP, Sfikakis PP. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J Rheumatol 2012, 39:60-62. 10.3899/jrheum.110617, 22133618.
48. Rees F, Jenkins W, Doherty M. Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis 2013, 72:826-830. 10.1136/annrheumdis-2012-201676, 22679303.
49. Lambert BL, Butin DN, Moran D, Zhao SZ, Carr BC, Chen C, Kizis FJ. Arthritis care: comparison of physicians' and patients' views. Semin Arthritis Rheum 2000, 30:100-110. 10.1053/sarh.2000.9203, 11071581.
50. Wells AF, MacDonald PA, Chefo S, Jackson RL. African American patients with gout: efficacy and safety of febuxostat vs allopurinol. BMC Musculoskelet Disord 2012, 13:15. 10.1186/1471-2474-13-15, 3317813, 22316106.